Inhibition by lithium of the nitrergic relaxation of rat anococcygeus muscle

Nitric Oxide - Biology and Chemistry

Volumn 20, Issue 1, 2009, Pages 31-38

  Karimollah, Ali Reza ^a   Ghasemi, Mehdi ^a   Ghahremani, Mohammad Hossein ^b   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anococcygeus muscle; Lithium; Neuronal nitric oxide synthase; Nitric oxide; Nonadrenergic noncholinergic (NANC) relaxation; Rat

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ARGININE; GUANETHIDINE; LITHIUM; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOCOCCYGEUS MUSCLE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; EX VIVO STUDY; GENE EXPRESSION; LITHIUM BLOOD LEVEL; MALE; NEUROTRANSMISSION; NITRERGIC NERVE; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE RELAXATION; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANIMALS; ARGININE; ELECTRIC STIMULATION; LITHIUM CHLORIDE; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; NG-NITROARGININE METHYL ESTER; NITRERGIC NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITROPRUSSIDE; OXADIAZOLES; PHENYLEPHRINE; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; RATTUS;

EID: 55549113989     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.08.007     Document Type: Article

References (49)

1. Manji H.K., Moore G.J., and Chen G. Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked?. Biol. Psychiatry 46 (1999) 929-940
2. Wada A., Yokoo H., Yanagita T., and Kobayashi H. Lithium: Potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J. Pharmacol. Sci. 99 (2005) 307-321
3. Price L.H., and Heninger G.R. Lithium in the treatment of mood disorders. N. Eng. J. Med. 331 (1994) 591-598
4. Jope S., and Williams M.B. Lithium and brain signal transduction systems. Biochem. Pharmacol. 47 (1994) 429-441
5. Williams R.S.B., and Harwood A.J. Lithium therapy and signal transduction. Trends Pharmacol. Sci. 21 (2000) 61-64
6. Berridge M.J., and Irvine R.F. Inositol phosphates and cell signalling. Nature 341 (1989) 197-205
7. Nahorski S.R., Ragan C.I., and Challiss R.A. Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol. Sci. 12 (1991) 297-303
8. Klein P.S., and Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93 (1996) 8455-8459
9. Shaldubina A., Agam G., and Belmaker R.H. The mechanism of lithium action: state of the art, ten years later. Prog. Neuropsychopharmacol. Biol. Psychiatry 25 (2001) 855-866
10. Paoletti A.M., Piccirilli S., Costa N., Rotiroti D., Bagetta G., and Nistico G. Systemic administration of Nω-nitro-l-arginine methyl ester and indomethacin reduces the elevation of brain PGE2 content and prevents seizures and hippocampal damage evoked by LiCl and tacrine in rat. Exp. Neurol. 149 (1998) 349-355
11. Harvey B.H., Carstens M.E., and Taljaard J.J. Evidence that lithium induces a glutamatergic: nitric oxide-mediated response in rat brain. Neurochem. Res. 19 (1994) 469-474
12. Weerasinghe G.R., Rapoport S.I., and Bosetti F. The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways. Brain Res. Bull. 63 (2004) 485-489
13. Anai H., Ueta Y., Serino R., Nomura M., Nakashima Y., and Yamashita H. Activation of hypothalamic neuronal nitric oxide synthase in lithium-induced diabetes insipidus rats. Psychoneuroendocrinology 26 (2001) 1009-1020
14. Dehpour A.R., Aghadadashi H., Ghafourifar P., Roushanzamir F., Ghahremani M.H., Meysamee F., Rassaee N., and Koucharian A. Effect of chronic lithium administration on endothelium-dependent relaxation in rat aorta. Clin. Exp. Pharmacol. Physiol. 27 (2000) 55-59
15. Sadeghipour H., Ghasemi M., Ebrahimi F., and Dehpour A.R. Effect of lithium on endothelium-dependent and neurogenic relaxation of rat corpus cavernosum: role of nitric oxide pathway. Nitric Oxide 16 (2007) 54-63
16. Sadeghipour H., Ghasemi M., Nobakht M., Ebrahimi F., and Dehpour A.R. Effect of chronic lithium administration on endothelium-dependent relaxation of rat corpus cavernosum: the role of nitric oxide and cyclooxygenase pathways. BJU Int. 99 (2007) 177-182
17. Sadeghipour H., Dehghani M., Ghasemi M., Riazi K., Asadi S., Ebrahimi F., Honar H., Hajrasouliha A.R., Tavakoli S., Sianati S., and Dehpour A.R. The nonadrenergic noncholinergic-mediated relaxation of corpus cavernosum was impaired in chronic lithium-treated rats: improvement with l-arginine. Eur. J. Pharmacol. 586 (2008) 300-305
18. Ghasemi M., Karimollah A.R., and Dehpour A.R. Nitric oxide involvement in the effect of acute lithium administration on the nonadrenergic noncholinergic-mediated relaxation of rat gastric fundus. Nitric Oxide 17 (2007) 152-159
19. Ghasemi M., Sadeghipour H., Mosleh A., Sadeghipour H.R., Mani A.R., and Dehpour A.R. Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur. Neuropsychopharmacol. 18 (2008) 323-332
20. Rand M.J. Nitrergic neurotransmission: nitric oxide as a mediator of non-adrenergic noncholinergic neuro-effector transmission. Clin. Exp. Pharmacol. Physiol. 19 (1992) 147-169
21. Gibson A., and McFadzean L. Biology of the anococcygeus muscle. Int. Rev. Cytol. 205 (2001) 1-35
22. Brave S.R., Tucker J.F., Gibson A., Bishop A.E., Riveros-Moreno V., Moncada S., and Polak J.M. Localisation of nitric oxide synthase within non-adrenergic, non-cholinergic nerves in the mouse anococcygeus. Neurosci. Lett. 161 (1993) 93-96
23. Kasakov L., Belai A., Vlaskovska M., and Burnstock G. Noradrenergic-nitrergic interactions in the rat anococcygeus muscle: evidence for postjunctional modulation by nitric oxide. Br. J. Pharmacol. 112 (1994) 403-410
24. Dail W.G., Galloway B., and Bordegaray J. NADPH diaphorase innervation of the rat anococcygeus and retractor penis muscles. Neurosci. Lett. 160 (1993) 17-20
25. Hobbs A.J., and Gibson A. l-NG-nitro-arginine and its methyl ester are potent inhibitors on non-adrenergic, non-cholinergic transmission in the rat anococcygeus. Br. J. Pharmacol. 100 (1990) 749-752
26. Graham A.M., and Sneddon P. Evidence for nitric oxide as an inhibitory neurotransmitter in rabbit isolated anococcygeus. Eur. J. Pharmacol. 237 (1993) 93-99
27. Feifer A., and Carrier S. Pharmacotherapy for erectile dysfunction. Expert Opin. Investig. Drugs 17 (2008) 679-690
28. Takahashi T. Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J. Gastroenterol. 38 (2003) 421-430
29. Cellek S., Rodrigo J., Lobos E., Fernandez P., Serrano J., and Moncada S. Selective nitrergic neurodegeneration in diabetes mellitus-a nitric oxide-dependent phenomenon. Br. J. Pharmacol. 128 (1999) 1804-1812
30. Gillespie J.S. The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br. J. Pharmacol. 45 (1972) 404-416
31. Dehpour A.R., Seyyedi A., Rastegar H., Namiranian K., Moezi L., Sadeghipour H., Dehghani M., Jorjani M., Roushanzamir F., and Ahmadiani A. The nonadrenergic noncholinergic relaxation of anococcygeus muscles of bile duct-ligated rats. Eur. J. Pharmacol. 445 (2002) 31-36
32. Consensus Development Panel, Mood disorders: pharmacologic prevention of recurrences, Am. J. Psychiatry 142 (1985) 469-476.
33. Gelenberg A.J., Kane J.M., Keller M.B., et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N. Eng. J. Med. 321 (1989) 1489-1493
34. Honar H., Riazi K., Homayoun H., Demehri S., Dehghani M., Vafaie K., Ebrahimkhani M.R., Rashidi N., Gaskari S.A., and Dehpour A.R. Lithium inhibits the modulatory effects of morphine on susceptibility to pentylentetrazole-induced clonic seizure in mice. involvement of a nitric oxide pathway. Brain Res. 1029 (2004) 48-55
35. Dehpour A.R., Sadr S.S.H., Nouroddini M., Shadan F., Nourozi A., Farahani M., and Sahebgharani M. Comparison of simultaneous administration of lithium with l-NAME or l-arginine on morphine withdrawal syndrome in mice. Hum. Psychpharmacol. Clin. Exp. 15 (2000) 87-93
36. Bagetta G., Corasaniti M.T., Melino G., Paoletti A.M., Finazzi-Agro A., and Nistico G. Lithium and tacrine increase the expression of nitric oxide synthase mRNA in the hippocampus of rat. Biochem. Biophys. Res. Commun. 197 (1993) 1132-1139
37. Feinstein D.L. Potentiation of astroglial nitric oxide synthase type-2 expression by lithium chloride. J. Neurochem. 71 (1998) 883-886
38. Afsharimani B., Moezi L., Sadeghipour H., Rahimzadeh-Rofouyi B., Nobakht M., Sanatkar M., Ghahremani M.H., and Dehpour A.R. Effect of chronic lithium administration on endothelium-dependent relaxation of rat mesenteric bed: role of nitric oxide. Can. J. Physiol. Pharmacol. 85 (2007) 1038-1046
39. Sartori C., Lepori M., and Scherrer U. Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans. Pharmacol. Ther. 106 (2005) 209-220
40. Maruta S., Suzuki E., Yokoyama M., Sato T., Inada K., Watanabe S., and Miyaoka H. Effects of intraperitoneally injected lithium, imipramine and diazepam on nitrate levels in rat amygdale. Psychiatry Clin. Neurosci. 59 (2005) 358-361
41. Wegener G., Bandpey Z., Heiberg I.L., Volke V., Trabace L., Rosenberg R., and Harvey B.H. Combined chronic treatment with citalopram and lithium does not modify the regional neurochemistry of nitric oxide in rat brain. J. Physiol. Pharmacol. 55 (2004) 575-586
42. Hashioka S., Klegeris A., Monji A., Kato T., Sawada M., McGeer P.L., and Kanba S. Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide. Exp. Neurol. 206 (2007) 33-42
43. Toda N., and Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol. Rev. 55 (2003) 271-324
44. Lacolley P.J., Lewis S.J., and Brody M.J. Role of sympathetic nerve activity in the generation of vascular nitric oxide in urethane-anesthetized rats. Hypertension 17 (1991) 881-887
45. G-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?. Biochem. Biophys. Res. Commun. 160 (1989) 881-886
46. Somlyo A.V., Walker J.W., Goldman Y.E., Trentham D.R., Kobayashi S., Kitazawa T., and Somlyo A.V. Inositol tris-phosphate, calcium and muscle contraction. Philos. Trans. R. Soc. Lond. B Biol. Sci. 320 (1988) 399-414
47. Hori M., Shimuzu K., Nakajyo S., and Urakawa N. Inhibitory effects of lithium on muscle contractions caused by various stimulants in guinea-pig ileum. Eur. J. Pharmacol. 165 (1989) 63-70
48. Karaki H., Ozaki H., Hori M., Mitsu-saito M., Amano KI., Harada KI., Miyamoto S., Nakazawa H., Won KJ., and Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 49 (1997) 157-230
49. + on contractile elements of intestinal smooth muscle. Jpn. J. Pharmacol. 68 (1995) 111-118